Skip to main content
. 2021 Nov;24(11):1546–1553. doi: 10.22038/IJBMS.2021.57053.12716

Figure 7.

Figure 7

Challenges tests. The BALB/c mice was infected intranasally with influenza virus A/PR8/34(H1N1) and monitored for 2 weeks daily. a: survival percent, b: body temperature and c: body weight. In comparison with commercial vaccines and the negative control group, Hemagglutinin-Montanide ISA71 revealed less mortality rate, body temperature and weight change